IDEAYA Biosciences (IDYA)

IDEAYA Biosciences (IDYA) Financial Statements


IDEAYA Biosciences Financial Overview

IDEAYA Biosciences's market cap is currently ―. The company's EPS TTM is $-1.522; its P/E ratio is -16.33; IDEAYA Biosciences is scheduled to report earnings on August 14, 2023, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 7.88M$ 4.02M$ 29.70M$ 5.85M$ 11.36M
Gross Profit$ 7.88M$ 4.02M---
EBIT$ -26.28M$ -26.44M$ 660.00K$ -22.50M$ -14.22M
EBITDA$ -26.88M$ -27.54M$ 1.58M$ -21.30M$ -13.76M
Net Income Common Stockholders$ -23.64M$ -24.20M$ 1.61M$ -22.06M$ -16.11M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 339.47M$ 364.83M$ 386.24M$ 268.62M$ 252.60M
Total Assets$ 364.75M$ 387.97M$ 410.91M$ 338.01M$ 358.87M
Total Debt$ 3.03M$ 3.48M$ 3.92M$ 4.36M$ 4.77M
Net Debt$ -336.44M$ -361.35M$ -382.32M$ -264.26M$ -247.83M
Total Liabilities$ 30.94M$ 38.51M$ 42.14M$ 68.69M$ 70.20M
Stockholders Equity$ 333.81M$ 349.45M$ 368.77M$ 269.32M$ 288.67M
Cash Flow-
Free Cash Flow$ -27.89M$ -23.37M$ -25.27M$ -21.93M$ -20.05M
Operating Cash Flow$ -27.84M$ -23.37M$ -24.17M$ -19.99M$ -19.65M
Investing Cash Flow$ 23.52M$ -10.28M$ -18.68M$ 13.32M$ -17.76M
Financing Cash Flow$ 2.93M$ 324.00K$ 95.70M$ 491.00K$ 653.00K
Currency in USD

IDEAYA Biosciences Earnings and Revenue History

IDEAYA Biosciences Debt to Assets

IDEAYA Biosciences Cash Flow

IDEAYA Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis